Listed

Maxcyte, Inc.

MXCTNasdaqCIK 1287098IndustrialsFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$4.9m, Q2 FY2026
Operating income−$10.2m, Q2 FY2026
Net income−$8.9m, Q2 FY2026
Maxcyte, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m4.2Revenue, Q3 FY2023, three months to 2023-09-30$4.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure4.8Revenue, Q4 FY2023, three months to 2023-12-31$4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001558370-25-002721. Derived: 12-month figure less the 9-month figure.Report this figure5.6Revenue, Q1 FY2024, three months to 2024-03-31$5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure5.0Revenue, Q2 FY2024, three months to 2024-06-30$5.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure5.6Revenue, Q3 FY2024, three months to 2024-09-30$5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure6.1Revenue, Q4 FY2024, three months to 2024-12-31$6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure5.7Revenue, Q1 FY2025, three months to 2025-03-31$5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure5.8Revenue, Q2 FY2025, three months to 2025-06-30$5.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure4.6Revenue, Q3 FY2025, three months to 2025-09-30$4.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure4.8Revenue, Q4 FY2025, three months to 2025-12-31$4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure4.5Revenue, Q1 FY2026, three months to 2026-03-31$4.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure4.9Revenue, Q2 FY2026, three months to 2026-06-30$4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Cost of revenue$m0.8Cost of revenue, Q3 FY2023, three months to 2023-09-30$793.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure1.6Cost of revenue, Q4 FY2023, three months to 2023-12-31$1.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-11, accession 0001558370-25-002721. Derived: 12-month figure less the 9-month figure.Report this figure1.4Cost of revenue, Q1 FY2024, three months to 2024-03-31$1.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure1.5Cost of revenue, Q2 FY2024, three months to 2024-06-30$1.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure1.9Cost of revenue, Q3 FY2024, three months to 2024-09-30$1.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure2.3Cost of revenue, Q4 FY2024, three months to 2024-12-31$2.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure1.5Cost of revenue, Q1 FY2025, three months to 2025-03-31$1.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure1.5Cost of revenue, Q2 FY2025, three months to 2025-06-30$1.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure1.6Cost of revenue, Q3 FY2025, three months to 2025-09-30$1.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure1.6Cost of revenue, Q4 FY2025, three months to 2025-12-31$1.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure1.6Cost of revenue, Q1 FY2026, three months to 2026-03-31$1.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure1.7Cost of revenue, Q2 FY2026, three months to 2026-06-30$1.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Gross profit$m7.2Gross profit, Q3 FY2023, three months to 2023-09-30$7.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure14.1Gross profit, Q4 FY2023, three months to 2023-12-31$14.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-11, accession 0001558370-25-002721. Derived: 12-month figure less the 9-month figure.Report this figure9.9Gross profit, Q1 FY2024, three months to 2024-03-31$9.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure8.9Gross profit, Q2 FY2024, three months to 2024-06-30$8.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure6.2Gross profit, Q3 FY2024, three months to 2024-09-30$6.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure6.4Gross profit, Q4 FY2024, three months to 2024-12-31$6.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure8.9Gross profit, Q1 FY2025, three months to 2025-03-31$8.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure7.0Gross profit, Q2 FY2025, three months to 2025-06-30$7.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure5.2Gross profit, Q3 FY2025, three months to 2025-09-30$5.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure5.7Gross profit, Q4 FY2025, three months to 2025-12-31$5.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure8.1Gross profit, Q1 FY2026, three months to 2026-03-31$8.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure5.6Gross profit, Q2 FY2026, three months to 2026-06-30$5.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Research and development$m6.3Research and development, Q3 FY2023, three months to 2023-09-30$6.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure5.8Research and development, Q4 FY2023, three months to 2023-12-31$5.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-11, accession 0001558370-25-002721. Derived: 12-month figure less the 9-month figure.Report this figure6.7Research and development, Q1 FY2024, three months to 2024-03-31$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure5.6Research and development, Q2 FY2024, three months to 2024-06-30$5.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure5.3Research and development, Q3 FY2024, three months to 2024-09-30$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure4.6Research and development, Q4 FY2024, three months to 2024-12-31$4.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure5.9Research and development, Q1 FY2025, three months to 2025-03-31$5.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure6.3Research and development, Q2 FY2025, three months to 2025-06-30$6.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure5.3Research and development, Q3 FY2025, three months to 2025-09-30$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure3.3Research and development, Q4 FY2025, three months to 2025-12-31$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure3.9Research and development, Q1 FY2026, three months to 2026-03-31$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure4.3Research and development, Q2 FY2026, three months to 2026-06-30$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Operating income$m(14.0)Operating income, Q3 FY2023, three months to 2023-09-30−$14.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure(8.1)Operating income, Q4 FY2023, three months to 2023-12-31−$8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-11, accession 0001558370-25-002721. Derived: 12-month figure less the 9-month figure.Report this figure(12.3)Operating income, Q1 FY2024, three months to 2024-03-31−$12.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure(12.0)Operating income, Q2 FY2024, three months to 2024-06-30−$12.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure(14.1)Operating income, Q3 FY2024, three months to 2024-09-30−$14.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure(12.9)Operating income, Q4 FY2024, three months to 2024-12-31−$12.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure(12.3)Operating income, Q1 FY2025, three months to 2025-03-31−$12.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(14.2)Operating income, Q2 FY2025, three months to 2025-06-30−$14.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure(14.1)Operating income, Q3 FY2025, three months to 2025-09-30−$14.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure(11.2)Operating income, Q4 FY2025, three months to 2025-12-31−$11.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure(6.2)Operating income, Q1 FY2026, three months to 2026-03-31−$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(10.2)Operating income, Q2 FY2026, three months to 2026-06-30−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(11.3)Net income, Q3 FY2023, three months to 2023-09-30−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure(5.3)Net income, Q4 FY2023, three months to 2023-12-31−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-11, accession 0001558370-25-002721. Derived: 12-month figure less the 9-month figure.Report this figure(9.5)Net income, Q1 FY2024, three months to 2024-03-31−$9.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure(9.4)Net income, Q2 FY2024, three months to 2024-06-30−$9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure(11.6)Net income, Q3 FY2024, three months to 2024-09-30−$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure(10.6)Net income, Q4 FY2024, three months to 2024-12-31−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure(10.3)Net income, Q1 FY2025, three months to 2025-03-31−$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure(12.4)Net income, Q2 FY2025, three months to 2025-06-30−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure(12.4)Net income, Q3 FY2025, three months to 2025-09-30−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure(9.6)Net income, Q4 FY2025, three months to 2025-12-31−$9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure(4.8)Net income, Q1 FY2026, three months to 2026-03-31−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure(8.9)Net income, Q2 FY2026, three months to 2026-06-30−$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Diluted EPS$ per share(0.11)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figurenot reportednot reported(0.09)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure(0.11)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figurenot reported(0.10)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(0.12)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure(0.12)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figurenot reported(0.04)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(0.08)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Basic EPS$ per share(0.11)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figurenot reported(0.09)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure(0.09)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure(0.11)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figurenot reported(0.10)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(0.12)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure(0.12)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figurenot reported(0.04)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(0.08)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure

Balance sheet

Cash and equivalents$15.0m, Q2 FY2026
Shareholders' equity$158.8m, Q2 FY2026
Maxcyte, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m49.2Cash and equivalents, Q3 FY2023, at 2023-09-30$49.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001558370-23-018314.Report this figure46.5Cash and equivalents, FY2023, at 2023-12-31$46.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-11, accession 0001558370-25-002721.Report this figure22.2Cash and equivalents, Q1 FY2024, at 2024-03-31$22.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0001558370-24-007085.Report this figure37.5Cash and equivalents, Q2 FY2024, at 2024-06-30$37.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001558370-24-011120.Report this figure37.0Cash and equivalents, Q3 FY2024, at 2024-09-30$37.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure27.9Cash and equivalents, FY2024, at 2024-12-31$27.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure23.4Cash and equivalents, Q1 FY2025, at 2025-03-31$23.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure15.2Cash and equivalents, Q2 FY2025, at 2025-06-30$15.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure13.0Cash and equivalents, Q3 FY2025, at 2025-09-30$13.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure20.1Cash and equivalents, FY2025, at 2025-12-31$20.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure14.6Cash and equivalents, Q1 FY2026, at 2026-03-31$14.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure15.0Cash and equivalents, Q2 FY2026, at 2026-06-30$15.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Current assets$m214Current assets, Q3 FY2023, at 2023-09-30$214.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001558370-23-018314.Report this figure190Current assets, FY2023, at 2023-12-31$190.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-11, accession 0001558370-25-002721.Report this figure179Current assets, Q1 FY2024, at 2024-03-31$178.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001558370-24-007085.Report this figure176Current assets, Q2 FY2024, at 2024-06-30$175.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-011120.Report this figure173Current assets, Q3 FY2024, at 2024-09-30$172.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure172Current assets, FY2024, at 2024-12-31$171.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure156Current assets, Q1 FY2025, at 2025-03-31$155.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure143Current assets, Q2 FY2025, at 2025-06-30$143.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure125Current assets, Q3 FY2025, at 2025-09-30$124.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure118Current assets, FY2025, at 2025-12-31$118.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure123Current assets, Q1 FY2026, at 2026-03-31$122.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure121Current assets, Q2 FY2026, at 2026-06-30$121.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Total assets$m267Total assets, Q3 FY2023, at 2023-09-30$266.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001558370-23-018314.Report this figure268Total assets, FY2023, at 2023-12-31$268.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-11, accession 0001558370-25-002721.Report this figure258Total assets, Q1 FY2024, at 2024-03-31$257.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001558370-24-007085.Report this figure251Total assets, Q2 FY2024, at 2024-06-30$251.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001558370-24-011120.Report this figure249Total assets, Q3 FY2024, at 2024-09-30$248.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure239Total assets, FY2024, at 2024-12-31$239.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure230Total assets, Q1 FY2025, at 2025-03-31$230.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure220Total assets, Q2 FY2025, at 2025-06-30$219.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure213Total assets, Q3 FY2025, at 2025-09-30$213.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure203Total assets, FY2025, at 2025-12-31$202.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure194Total assets, Q1 FY2026, at 2026-03-31$194.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure185Total assets, Q2 FY2026, at 2026-06-30$184.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Current liabilities$m16.6Current liabilities, Q3 FY2023, at 2023-09-30$16.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001558370-23-018314.Report this figure17.9Current liabilities, FY2023, at 2023-12-31$17.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-11, accession 0001558370-25-002721.Report this figure13.5Current liabilities, Q1 FY2024, at 2024-03-31$13.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001558370-24-007085.Report this figure12.3Current liabilities, Q2 FY2024, at 2024-06-30$12.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-011120.Report this figure17.6Current liabilities, Q3 FY2024, at 2024-09-30$17.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure15.8Current liabilities, FY2024, at 2024-12-31$15.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure12.7Current liabilities, Q1 FY2025, at 2025-03-31$12.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure11.6Current liabilities, Q2 FY2025, at 2025-06-30$11.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure16.1Current liabilities, Q3 FY2025, at 2025-09-30$16.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure14.3Current liabilities, FY2025, at 2025-12-31$14.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure10.2Current liabilities, Q1 FY2026, at 2026-03-31$10.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure9.9Current liabilities, Q2 FY2026, at 2026-06-30$9.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Total liabilities$m33.4Total liabilities, Q3 FY2023, at 2023-09-30$33.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001558370-23-018314.Report this figure36.1Total liabilities, FY2023, at 2023-12-31$36.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-11, accession 0001558370-25-002721.Report this figure31.6Total liabilities, Q1 FY2024, at 2024-03-31$31.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001558370-24-007085.Report this figure30.2Total liabilities, Q2 FY2024, at 2024-06-30$30.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001558370-24-011120.Report this figure35.3Total liabilities, Q3 FY2024, at 2024-09-30$35.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure33.2Total liabilities, FY2024, at 2024-12-31$33.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure30.5Total liabilities, Q1 FY2025, at 2025-03-31$30.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure29.0Total liabilities, Q2 FY2025, at 2025-06-30$29.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure33.2Total liabilities, Q3 FY2025, at 2025-09-30$33.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure31.0Total liabilities, FY2025, at 2025-12-31$31.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure26.6Total liabilities, Q1 FY2026, at 2026-03-31$26.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure25.9Total liabilities, Q2 FY2026, at 2026-06-30$25.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure
Shareholders' equity$m233Shareholders' equity, Q3 FY2023, at 2023-09-30$233.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure232Shareholders' equity, FY2023, at 2023-12-31$232.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-25, accession 0001104659-26-034557.Report this figure226Shareholders' equity, Q1 FY2024, at 2024-03-31$226.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure221Shareholders' equity, Q2 FY2024, at 2024-06-30$221.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure213Shareholders' equity, Q3 FY2024, at 2024-09-30$213.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure206Shareholders' equity, FY2024, at 2024-12-31$206.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure199Shareholders' equity, Q1 FY2025, at 2025-03-31$199.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure191Shareholders' equity, Q2 FY2025, at 2025-06-30$190.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure180Shareholders' equity, Q3 FY2025, at 2025-09-30$180.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure171Shareholders' equity, FY2025, at 2025-12-31$171.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure168Shareholders' equity, Q1 FY2026, at 2026-03-31$167.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure159Shareholders' equity, Q2 FY2026, at 2026-06-30$158.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure

Cash flow

Operating cash flow−$4.7m, Q2 FY2026
Capital expenditure$62.0k, Q2 FY2026
Maxcyte, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(8.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0001558370-24-014662. Derived: 9-month figure less the 6-month figure.Report this figure1.0Operating cash flow, Q4 FY2023, three months to 2023-12-31$981.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-11, accession 0001558370-25-002721. Derived: 12-month figure less the 9-month figure.Report this figure(10.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$10.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure(4.8)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001558370-25-010554. Derived: 6-month figure less the 3-month figure.Report this figure(4.4)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001104659-25-111396. Derived: 9-month figure less the 6-month figure.Report this figure(7.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$7.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure(14.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$14.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(9.9)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001104659-26-095971. Derived: 6-month figure less the 3-month figure.Report this figure(7.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$7.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001104659-25-111396. Derived: 9-month figure less the 6-month figure.Report this figure(2.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure(8.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure(4.7)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001104659-26-095971. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.7Capital expenditure, Q3 FY2023, three months to 2023-09-30$720.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0001558370-24-014662. Derived: 9-month figure less the 6-month figure.Report this figure0.9Capital expenditure, Q4 FY2023, three months to 2023-12-31$915.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-11, accession 0001558370-25-002721. Derived: 12-month figure less the 9-month figure.Report this figure0.8Capital expenditure, Q1 FY2024, three months to 2024-03-31$804.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure0.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$294.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001558370-25-010554. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2024, three months to 2024-09-30$406.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001104659-25-111396. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$147.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure0.7Capital expenditure, Q1 FY2025, three months to 2025-03-31$653.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure0.6Capital expenditure, Q2 FY2025, three months to 2025-06-30$584.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001104659-26-095971. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2025, three months to 2025-09-30$300.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001104659-25-111396. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$231.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001104659-26-034557. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$72.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$62.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001104659-26-095971. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)106.82m, Q2 FY2026
Maxcyte, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares102Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30101,806,173 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001558370-23-018314.Report this figure103Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31102,846,036 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-10, accession 0001558370-23-009167.Report this figure103Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30103,063,606 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001558370-24-011120.Report this figure103Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30103,449,715 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0001558370-24-014662.Report this figure104Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31104,089,758 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001558370-25-007005.Report this figure105Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30104,639,239 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001558370-25-010554.Report this figure105Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30105,109,603 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure106Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31105,950,480 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure106Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30106,403,540 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure107Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30106,613,075 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001104659-25-111396.Report this figure107Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31106,875,087 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001104659-26-060290.Report this figure107Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30106,822,633 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure

Shares outstanding: 103.21mShares outstanding, period not labelled, at 2026-08-07103,206,206 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001104659-26-095971.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. Listed shows no prices and gives no investment advice.